Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xilio Therapeutics, Inc. | 24,766 | reported | 02 Jan 2026 | tx 31+3,439,121−1,055,996 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | SALE | Xilio Therapeutics, Inc. | 7,030 | 0.64 USD | |
| 01 Jan 2026 | EXERCISE | Xilio Therapeutics, Inc. | 19,375 | — | |
| 01 Jan 2026 | EXERCISE | Xilio Therapeutics, Inc. | 19,375 | 0.00 USD | deriv |
| 31 Dec 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 668,789 | 0.00 USD | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 45,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 23,786 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 23,786 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 155,090 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 155,090 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 925,000 | 0.00 USD | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 300,000 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 300,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 150,000 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 150,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 117,000 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 117,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 20,000 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 20,000 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 45,000 | — | deriv |
| 21 Nov 2025 | OTHER | Xilio Therapeutics, Inc. | 37,296 | — | deriv |
| 21 Nov 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 37,296 | — | deriv |
| 15 Apr 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 01 Jan 2025 | EXERCISE | Xilio Therapeutics, Inc. | 19,375 | — | |
| 02 Jan 2025 | SALE | Xilio Therapeutics, Inc. | 6,954 | 0.98 USD | |
| 01 Jan 2025 | GRANT_AWARD | Xilio Therapeutics, Inc. | 251,000 | 0.00 USD | deriv |